Skip to main content

3 Reasons to Sell BBWI and 1 Stock to Buy Instead

BBWI Cover Image

What a brutal six months it’s been for Bath and Body Works. The stock has dropped 27.9% and now trades at $27.80, rattling many shareholders. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.

Is now the time to buy Bath and Body Works, or should you be careful about including it in your portfolio? Dive into our full research report to see our analyst team’s opinion, it’s free.

Why Is Bath and Body Works Not Exciting?

Despite the more favorable entry price, we're sitting this one out for now. Here are three reasons why we avoid BBWI and a stock we'd rather own.

1. Shrinking Same-Store Sales Indicate Waning Demand

Same-store sales is an industry measure of whether revenue is growing at existing stores, and it is driven by customer visits (often called traffic) and the average spending per customer (ticket).

Bath and Body Works’s demand has been shrinking over the last two years as its same-store sales have averaged 2.8% annual declines.

Bath and Body Works Same-Store Sales Growth

2. Projected Revenue Growth Is Slim

Forecasted revenues by Wall Street analysts signal a company’s potential. Predictions may not always be accurate, but accelerating growth typically boosts valuation multiples and stock prices while slowing growth does the opposite.

Over the next 12 months, sell-side analysts expect Bath and Body Works’s revenue to rise by 2.3%, a deceleration versus This projection is underwhelming and implies its products will see some demand headwinds.

3. EPS Barely Growing

We track the long-term change in earnings per share (EPS) because it highlights whether a company’s growth is profitable.

Bath and Body Works’s EPS grew at an unimpressive 9.1% compounded annual growth rate over the last six years. On the bright side, this performance was better than its 6.7% annualized revenue growth and tells us the company became more profitable on a per-share basis as it expanded.

Bath and Body Works Trailing 12-Month EPS (GAAP)

Final Judgment

Bath and Body Works’s business quality ultimately falls short of our standards. Following the recent decline, the stock trades at 7.6× forward P/E (or $27.80 per share). While this valuation is reasonable, we don’t really see a big opportunity at the moment. We're fairly confident there are better stocks to buy right now. Let us point you toward the most entrenched endpoint security platform on the market.

High-Quality Stocks for All Market Conditions

Donald Trump’s victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.

While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.